George A. Scangos, President and CEO at Vir Biotechnology, Inc. (VIR), sold 55,500 shares at $22.74 ($1.4M) on 2023-02-24, disclosed to the SEC on 2023-02-24.
Open-market sale of $1.4M VIR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.97 | 12,631 | $328K | 24.1% |
| 2 | $25.97 | 12,631 | $328K | 24.1% |
| 3 | $22.74 | 4,239 | $96K | 7.1% |
| 4 | $22.74 | 4,239 | $96K | 7.1% |
| 5 | $23.56 | 10,880 | $256K | 18.8% |
| 6 | $23.56 | 10,880 |
| $256K |
| 18.8% |
| Total | $24.53 avg | 55,500 | $1.4M | 100% |
| Filing → |
| VIR | SELL | 2024-02-26 | $614K | — | Filing → |
| VIR | SELL | 2024-02-20 | $568K | — | Filing → |
| VIR | SELL | 2023-02-21 | $1.5M | — | Filing → |